120 related articles for article (PubMed ID: 22307076)
1. Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines.
Adler D; Ochsenfahrt J; Fuchs K; Wernert N
Oncol Rep; 2012 May; 27(5):1321-4. PubMed ID: 22307076
[TBL] [Abstract][Full Text] [Related]
2. The caspase-generated cleavage product of Ets-1 p51 and Ets-1 p27, Cp17, induces apoptosis.
Choul-Li S; Tulasne D; Aumercier M
Biochem Biophys Res Commun; 2016 Nov; 480(1):1-7. PubMed ID: 27737766
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines.
Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
Int J Mol Med; 2011 Jul; 28(1):89-93. PubMed ID: 21491078
[TBL] [Abstract][Full Text] [Related]
4. Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51.
Laitem C; Leprivier G; Choul-Li S; Begue A; Monte D; Larsimont D; Dumont P; Duterque-Coquillaud M; Aumercier M
Oncogene; 2009 May; 28(20):2087-99. PubMed ID: 19377509
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of effects caused by differentially spliced Ets-1 transcripts in fibroblasts.
Hahne JC; Fuchs T; Florin A; Edwards D; Pourtier A; Soncin F; Wernert N
Int J Oncol; 2011 Nov; 39(5):1073-82. PubMed ID: 21833469
[TBL] [Abstract][Full Text] [Related]
6. Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function.
Choul-Li S; Leroy C; Leprivier G; Laitem C; Tulasne D; Aumercier M
Biochem J; 2010 Feb; 426(2):229-41. PubMed ID: 20001963
[TBL] [Abstract][Full Text] [Related]
7. Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.
Adler D; Langer B; Lindstrot A; Florin A; Bosserhoff A; Buettner R; Wernert N
Oncol Rep; 2011 Apr; 25(4):1125-9. PubMed ID: 21258770
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.
Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
Int J Mol Med; 2011 Jun; 27(6):811-9. PubMed ID: 21424114
[TBL] [Abstract][Full Text] [Related]
9. ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.
Adler D; Ochsenfahrt J; Fuchs K; Kristiansen G; Perner S; Wernert N
Int J Mol Med; 2012 Nov; 30(5):1029-33. PubMed ID: 22922762
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
12. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines.
Adler D; Lindstrot A; Ochsenfahrt J; Fuchs K; Wernert N
Int J Mol Med; 2013 Jan; 31(1):21-5. PubMed ID: 23135352
[TBL] [Abstract][Full Text] [Related]
14. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation.
Koizumi S; Fisher RJ; Fujiwara S; Jorcyk C; Bhat NK; Seth A; Papas TS
Oncogene; 1990 May; 5(5):675-81. PubMed ID: 2189104
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation.
Lulli V; Romania P; Riccioni R; Boe A; Lo-Coco F; Testa U; Marziali G
Haematologica; 2010 Oct; 95(10):1633-41. PubMed ID: 20435626
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
17. Ets-1 p51 and p42 isoforms differentially modulate Stromelysin-1 promoter according to induced DNA bend orientation.
Leprivier G; Baillat D; Begue A; Hartmann B; Aumercier M
Nucleic Acids Res; 2009 Jul; 37(13):4341-52. PubMed ID: 19465391
[TBL] [Abstract][Full Text] [Related]
18. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
19. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.
Paulo P; Ribeiro FR; Santos J; Mesquita D; Almeida M; Barros-Silva JD; Itkonen H; Henrique R; Jerónimo C; Sveen A; Mills IG; Skotheim RI; Lothe RA; Teixeira MR
Neoplasia; 2012 Jul; 14(7):600-11. PubMed ID: 22904677
[TBL] [Abstract][Full Text] [Related]
20. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.
Berglund AE; Rounbehler RJ; Gerke T; Awasthi S; Cheng CH; Takhar M; Davicioni E; Alshalalfa M; Erho N; Klein EA; Freedland SJ; Ross AE; Schaeffer EM; Trock BJ; Den RB; Cleveland JL; Park JY; Dhillon J; Yamoah K
Prostate Cancer Prostatic Dis; 2019 May; 22(2):292-302. PubMed ID: 30367117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
